Summary
A 68-year-old man with a severe ischemic cardiomyopathy underwent left ventricular assist device (LVAD) implantation (Heart Mate II device) for destination therapy. He presented 49 months after LVAD implantation with worsening heart failure symptoms and new severe aortic regurgitation. Given high risk for both surgical and transcatheter aortic valve replacement, he was admitted for transcatheter closure of the aortic valve under transesophageal echocardiographic (TEE) guidance. TEE imaging revealed severe aortic regurgitation (Fig. 1A and B and Videos 1 and 2). Under TEE and fluoroscopic guidance, a 25 mm Amplatzer cribriform atrial septal defect closure device was advanced across the aortic valve (Fig. 1C and D and Videos 3 and 4). Immediately after device deployment, TEE revealed a well-seated device with complete aortic valve closure and trivial aortic regurgitation (Fig. 2A, B, C and D and Videos 5, 6, 7 and 8). Subsequent transthoracic echocardiograms obtained from 74 to 172 days after the procedure revealed no residual aortic regurgitation. The patient awoke with diffuse urticaria 244 days after the procedure and died en route to the emergency department, presumably secondary to a systemic allergic reaction. De novo aortic regurgitation is increasingly recognized in patients with LVADs (1). TEE-guided transcatheter aortic valve closure is an option in these high-risk patients (2).

(A) Mid-esophageal long-axis image revealing severe aortic regurgitation (white arrow). (B) Mid-esophageal short-axis image demonstrating severe central aortic regurgitation (white arrow). (C) Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribriform atrial septal defect closure device in the left ventricle (white arrow). (D) Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribriform atrial septal defect closure device in the left ventricle (white arrow), and the left atrial disc in the ascending aorta.
Citation: Echo Research and Practice 4, 2; 10.1530/ERP-17-0003

(A) Mid-esophageal long-axis image revealing severe aortic regurgitation (white arrow). (B) Mid-esophageal short-axis image demonstrating severe central aortic regurgitation (white arrow). (C) Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribriform atrial septal defect closure device in the left ventricle (white arrow). (D) Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribriform atrial septal defect closure device in the left ventricle (white arrow), and the left atrial disc in the ascending aorta.
Citation: Echo Research and Practice 4, 2; 10.1530/ERP-17-0003
(A) Mid-esophageal long-axis image revealing severe aortic regurgitation (white arrow). (B) Mid-esophageal short-axis image demonstrating severe central aortic regurgitation (white arrow). (C) Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribriform atrial septal defect closure device in the left ventricle (white arrow). (D) Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribriform atrial septal defect closure device in the left ventricle (white arrow), and the left atrial disc in the ascending aorta.
Citation: Echo Research and Practice 4, 2; 10.1530/ERP-17-0003

(A) Mid-esophageal short-axis image after device deployment with a closed aortic valve (white arrow). (B) Mid-esophageal long-axis image after device deployment with a closed aortic valve (white arrow). (C) Mid-esophageal long-axis image revealing trivial aortic regurgitation (with minimal flow between the 2 device discs) (white arrow). (D) Three-dimensional en face view (ascending aorta perspective) after device deployment.
Citation: Echo Research and Practice 4, 2; 10.1530/ERP-17-0003

(A) Mid-esophageal short-axis image after device deployment with a closed aortic valve (white arrow). (B) Mid-esophageal long-axis image after device deployment with a closed aortic valve (white arrow). (C) Mid-esophageal long-axis image revealing trivial aortic regurgitation (with minimal flow between the 2 device discs) (white arrow). (D) Three-dimensional en face view (ascending aorta perspective) after device deployment.
Citation: Echo Research and Practice 4, 2; 10.1530/ERP-17-0003
(A) Mid-esophageal short-axis image after device deployment with a closed aortic valve (white arrow). (B) Mid-esophageal long-axis image after device deployment with a closed aortic valve (white arrow). (C) Mid-esophageal long-axis image revealing trivial aortic regurgitation (with minimal flow between the 2 device discs) (white arrow). (D) Three-dimensional en face view (ascending aorta perspective) after device deployment.
Citation: Echo Research and Practice 4, 2; 10.1530/ERP-17-0003
Mid-esophageal long-axis image revealing severe aortic regurgitation. View Video 1 at http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0003/video-1.
Download Video 1
Mid-esophageal short-axis image demonstrating severe central aortic regurgitation. View Video 2 at http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0003/video-2.
Download Video 2
Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribriform atrial septal defect closure device in the left ventricle. View Video 3 at http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0003/video-3.
Download Video 3
Mid-esophageal long-axis image showing the right atrial disc of the Amplatzer cribiform atrial septal defect closure device in the left ventricle, and the left atrial disc in the ascending aorta. View Video 4 at http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0003/video-4.
Download Video 4
Mid-esophageal short-axis image after device deployment with a closed aortic valve. View Video 5 at http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0003/video-5.
Download Video 5
Mid-esophageal long-axis image after device deployment with a closed aortic valve. View Video 6 at http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0003/video-6.
Download Video 6
Mid-esophageal long-axis image revealing trivial aortic regurgitation (with minimal flow between the 2 device discs). View Video 7 at http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0003/video-7.
Download Video 7
Three-dimensional en face view (ascending aorta perspective) after device deployment. View Video 8 at http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0003/video-8.
Download Video 8
Declaration of interest
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this article.
Funding
This work did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector.
Patient consent
This patient is deceased. Written informed consent was received from the patient’s wife.
Author contribution statement
Preetham R Muskula: responsible for initial draft of manuscript; Taiyeb M Khumri: named physician of the patient; Michael L Main: oversight of the reported case.
References
- 1↑
Cowger J, Rao V, Massey T, Sun B, May-Newman K, Jorde U & Estep JD 2015 Comprehensive review and suggested strategies for the detection and management of aortic insufficiency in patient with a continuous-flow left ventricular assist device. Journal of Heart and Lung Transplantation 34 149–157. (doi:10.1016/j.healun.2014.09.045)
- 2↑
Parikh KS, Mehrota AK, Russo MJ, Lang RM, Anderson A, Jeevanandam V, Freed BH, Paul JD, Karol J, Nathan S & Shah AP 2013 Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device associated aortic insufficiency and improves cardiac hemodynamics. JACC: Cardiovascular Interventions 6 84–89. (doi:10.1016/j.jcin.2012.08.021)